Primary CEA+ (n = 17) tumors comprised colorectal cancer (n = 11), non-small cell lung cancer (n = 4), salivary gland cancer (n = 1), and gastric cancer (n = 1). This evidence concerns the gene CEACAM5 and colorectal cancer.